Navigation Links
Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
Date:5/11/2009

Pharmaceutical packaging equipment manufacturer, Sepha Ltd, enters strategic European alliances and gears up for business at world's major chemical processing congress in Frankfurt, Achema 2009

Belfast (Vocus) May 11, 2009 -- The Northern Ireland based manufacturer of innovative leak testing and de-blistering equipment, Sepha Ltd is boosting its European distribution network ahead of its attendance at the world’s leading event for the chemical processing industry. Gearing up to do business at Achema, the major pharmaceutical industry event held every 3 years in Frankfurt, Sepha has appointed ra pharmatechnik as its German agent and is also partnering with ADMC in France.

Sepha’s CEO, Aubrey Sayers explains how these relationships will help more customers avail of Sepha’s range of innovative machines: “Both agents have vast experience of the pharmaceutical packaging industry and understand customers’ requirements. We are delighted to be able to work with them in providing our leak testing and deblistering solutions that improve quality assurance, increase production throughput and, above all, save money.”

The Sepha range will be on show at Achema including BlisterScan, which is a non-destructive leak testing machine for blister packs. It can detect and locate leaks as small as 7 microns. Blister packs are scanned by a beam of light both before after a vacuum is applied. The difference between these scan readings is used to calculate the size of the hole in the blister pack. It is a non-destructive, clean, dry process so any packs that pass the test can be returned to the production line. Packs that fail the test can have the contents removed for repackaging using one of Sepha’s deblistering machines. The alternative Methylene blue dye test by comparison renders any tested blister packs unsaleable. PakScan is a similar non-destructive leak tester for pouches and sachets that can detect holes down to 10 microns.

Press-Out Manual is a small, portable, manual deblistering machine that is suitable for in-line push-through blister packs. It does not have any tooling to changeover and only takes about 3 minutes to set up for a new blister pack. It can de-blister up to 20 packs per minute and is operated manually by a handle. Press-Out Semi-automatic is a small, portable, semi-automatic deblistering machine that is suitable for push-through blister packs that have an in-line, diagonal or off-set format. It can de-blister up to 40 packs per minute. Packs are manually placed on the machine but then are fed through automatically. Set-up takes about 3 minutes. Press-Out Universal is the state-of-the-art automatic deblistering machine that is used by pharmaceutical manufacturers to recover tablets and capsules from blister packs, and is particularly suitable for fragile or expensive pills because of its gentle action.

It is suitable for all formats of push-through blister packs and also child resistant and peelable blister packs. Blister packs are automatically fed from the magazine into a cutting machine. A cut is made in the lidding material of the blister pack, around the base of the blister pocket. The tablets or capsules are then eased out of the blisters and collected separately from the packaging. Up to 50 blister packs can be de-blistered every minute, and tooling changeover takes about 5 minutes. EZ Blister is a lab-scale blister packing machine. It is suitable for runs of up to 20000 blister packs so is especially good for R&D labs. It forms, seals and cuts the blister packs and the resultant packs are of an equivalent quality to packs made on large automatic production lines.            

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2406914.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 24, 2017  VWR Corporation (NASDAQ: VWR), the leading global ... production customers, today reported its financial results for the fourth ... Highlights: 4Q16 record quarterly net sales ... an organic basis. 4Q16 EMEA-APAC ... basis, while the Americas net sales increased 2.5%, or down ...
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):